/Investor DB

Gilmartin Capital LLC

Venture capital

Larkspur · Series A–Late Stage · 2 people tracked

Find your way into Gilmartin Capital LLC

Each arrow is one introduction. Sign up to fill in the first one.

1,325 people can intro you to David

Ask Ryan Stroub to introduce you to David Lewis

You →Ryan · together at Thomas Weisel Partners →David

Sign up to find every way you can get introduced to Gilmartin Capital LLC

  • Your email: who you already know at Gilmartin Capital LLC, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gilmartin Capital LLC team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Gilmartin Capital invests in companies advancing platforms that address large or underserved diseases, technologies that accelerate scientific discovery, and solutions improving the cost, site, and delivery of care. The firm targets opportunities beyond proof of concept that are positioned for meaningful development and growth across the medical device, life science tool, diagnostic, and digital health sectors. Emphasizing insight over capital, Gilmartin offers domain expertise in strategy, market assessment, and capital markets advisory, drawing on a proprietary network of key opinion leaders and operators built over two decades. Much of its fund capital comes from healthcare operators.

Source: firm website, verified Sep 29, 2026.

Stage
Series A–Late Stage
HQ
Larkspur, US
Instruments
Equity
Founded
2021
Private fund assets
$61M
VC funds
1
Tracked investments
5
Acquisitions
1

Team · 2 people

from the firm's website

What they invest in

from 5 of 5 portfolio companies

Healthtech ×3Medical Devices ×3Biotech ×2AI & Machine Learning ×1Cleantech ×1Climate Tech ×1EdTech ×1Energy ×1

HQs:United States×3

Investments · 5 tracked

founders shown can be your intro path
Alleviant Medical Incalleviantmedical.comin𝕏Feb 2025

Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).

BiotechHealthtechMedical DevicesAustin, US

Adam Berman(Executive Officer, Director)inJacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)

BoardGeoff Pardo(Director)in

Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundCadence Healthcare VenturesGilde HealthcareOmega Funds+2 more

Galvanizegalvanize.comin𝕏Sep 2025 · $100M

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)Lawrence Mandes(Managing Director, New Markets)in

BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)

Co-investorsSofinnova PartnersTeamworthy VenturesThe Colorado Impact FundVTF CapitalAlly Bridge GroupCatalyst Investors+5 more

Galvanizegalvanizeclimate.comin𝕏Sep 2025 · $100MAcquired

Galvanize Climate Solutions is an investment firm focused on the energy transition, deploying capital across areas such as climate risk analytics and clean energy.

CleantechClimate TechEnergy

Veery Maxwell(Founder)in

Co-investorsABS Capital PartnersBlue Haven InitiativeGalvanize Climate SolutionsAlly Bridge GroupFidelity InvestmentsJanus Henderson Investors+4 more

Galvanize Therapeuticsgalvanizetx.cominSep 2025 · $100M

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.

BiotechHealthtechMedical DevicesRedwood City, US

Doug Godshall(Executive Officer, Director)inSteve Anheier(Executive Officer)in

BoardJonathan Waldstreicher(Executive Officer)Antoine Papiernik(Director)inSeth Harrison(Director)Zack Scott(Director)in

Co-investorsNorwest Venture PartnersAlly Bridge GroupATPFidelity InvestmentsJanus Henderson InvestorsPerceptive Xontogeny Venture+2 more

Insightecinsightec.comin𝕏

Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.

HealthtechMedical DevicesTirat Carmel

Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)inEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJun (Jim) Tao(Chief Operating Officer)inMaurice R. Ferre(Chairman and Chief Executive Officer)in

Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion Ventures+7 more

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Gilmartin Capital LLC made?
Gilmartin Capital LLC has 5 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
What stage does Gilmartin Capital LLC invest at?
Gilmartin Capital LLC invests at the Series A, Series B, Growth, Late Stage stages.
What sectors does Gilmartin Capital LLC focus on?
Gilmartin Capital LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Gilmartin Capital LLC located?
Gilmartin Capital LLC is headquartered in Larkspur, US.

Similar investors

Featured in lists